PATH-20. COMPREHENSIVE GENOMIC PROFILING COMPARING PRIMARY CNS LYMPHOMA TO SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA REVEALS BIOMARKERS INDICATING POTENTIAL BENEFIT FROM IMMUNE CHECKPOINT INHIBITORS

BACKGROUND: B-Cell Primary CNS Lymphoma (PCL) is Diffuse Large B-cell Lymphoma (DLBCL) confined to the CNS. Less than 50% of PCL patients achieve complete remission with current therapies. Comprehensive genomic profiling (CGP) may suggest novel treatment modalities including use of immune checkpoint...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Severson, Eric, Vergilio, Jo-Anne, Gay, Laurie, Daniel, Sugganth, Elvin, Julia, Suh, James, Covert, Mandy, Brown, Charlotte, Miller, Vincent, Stephens, Philip, Ross, Jeffrey, Ramkissoon, Shakti
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693113/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.711
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares